Treating Babies with Severe Jaundice in India

 
$11,050
$78,951
Raised
Remaining
Jul 25, 2011

What’s the global unmet need for treatment of severe neonatal jaundice?

When a baby is delivered at home and develops severe jaundice, it may not be clear to family members that they need to seek treatment.  As a result, the global health community has had difficulty estimating the unmet global need for jaundice treatment.  Working with colleagues at Stanford, D-Rev is doing just that – and trying to understand the variances by region. 

This is one of the topics we presented at the May 2011 Pediatric Academic Societies meeting in Denver, Colorado. We also presented the benchtop evaluation of Brilliance and a study of barriers to effective phototherapy treatment based on our work with colleagues in Nigeria. To see the posters, scroll to the bottom of this page. D-Rev and partners have also recently published on the need for affordable phototherapy in low-resources areas and technical guidelines for successful implementation of phototherapy there—the full paper can be found in Seminars in Perinatology

In addition to academic research, here are some other things we've been up to:

  • D-Rev’s partner Phoenix Medical Systems is in first pilot production with Brilliance.
  • Our photo above is of Jayanth chatting with a baby (and mom) at a hospital outside Chennai.  Brilliance is in the background!  See our full photo album here.
  • D-Rev is among the 77 finalists for USAID’s Saving Lives at Birth Challenge – out of 600 who applied. Please take a minute and vote for us for the People's Choice Award!

 

The D-Rev Team

Mar 21, 2011

Updates on Brilliance and what we're up to

First Built Brilliance
First Built Brilliance

Dear Global Giving supporters, 

Thank you very much for your generous support of Brilliance and our Neonatal Jaundice Initiative. Since December 2010, we've made some exciting progress, from licensing Brilliance to Phoenix Medical Systems, a local Indian medical device firm, for manufacturing and distribution, to taking orders from local hospitals and clinics for the phototherapy device. We expect Brilliance to arrive in hospitals and clinics by July 2011. In addition, we have been working with leading NGOs and medical experts to update tendering specifications of photothreapy devices in India so that effective treatment will increasingly be a standard for all newborns with jaundice. Thank you again for your continued support and we look forward to sharing the year ahead with you!

The D-Rev Team

Product Manager Jayanth with Brilliance at FAOPS
Product Manager Jayanth with Brilliance at FAOPS

Links:

About Project Reports

Project Reports on GlobalGiving are posted directly to globalgiving.org by Project Leaders as they are completed, generally every 3-4 months. To protect the integrity of these documents, GlobalGiving does not alter them; therefore you may find some language or formatting issues.

If you donate to this project or have donated to this project, you will get an e-mail when this project posts a report. You can also subscribe for reports via e-mail without donating or by subscribing to this project's RSS feed.

Retired Project

This project is no longer accepting donations.

Still want to help?
Find another project in India or in Health that needs your help.

Project Leader

Jayanth Chakravarthy

Palo Alto, CA United States

Where is this project located?

Map of Treating Babies with Severe Jaundice in India